Diagnostic clues for hyalinizing trabecular tumor on fine needle aspiration cytology
How to cite this article: Nielsen L, Colino Gallardo AM, Pérez Alonso P, Ortega Medina L, Latorre García E, Díaz del Arco C, et al. Diagnostic clues for hyalinizing trabecular tumor on fine needle aspiration cytology. CytoJournal 2023;20:19.
The hyalinizing trabecular tumor (HTT) is a rare benign neoplasm of the thyroid gland. This neoplasm has overlapping cytological features with Papillary Thyroid Carcinoma, Medullary Carcinoma and Follicular Neoplasm with Nuclear Features of Papillary Carcinoma. This can lead to misdiagnosis of malignancy in fine needle aspiration (FNA) cytology specimens with unnecessary total thyroidectomy. The aim of this study is to determine if there are some cytological features that could help us to suspect HTT on FNA specimens and avoid radical surgery.
Material and Methods:
With this purpose we have collected 6 cases diagnosed of HTT in Hospital Clínico San Carlos of Madrid (Spain) in the last 10 years and reviewed the cytological specimens.
We conclude that the presence of hyaline material in FNA specimens of HTT is a constant feature being a diagnostic clue. We must be cautious not to confuse it with dense colloid or amyloid material, the latter seen in Medullary Carcinoma. Papillary architecture and fibrovascular cores are not present in a HTT. Special stains as ki-67, calcitonin and Congo Red staining could help us in achieving the correct diagnosis.
We feel the cytopathologists must be aware of the distinguishing features of this lesion, mainly the typical hyaline material to achieve a proper diagnosis and be able to reduce unnecessary aggressive management of these patients.
Hyalinizing trabecular tumor
Fine needle aspiration
Hyalinizing trabecular tumor (HTT) is a distinct rare benign neoplasm of the thyroid gland, first described in 1987 by Carney et al.
This neoplasm arises from the follicular cells of the thyroid. It shows some architectural features that mimic malignancy on the fine needle aspiration (FNA) cytology specimens, including papillary thyroid carcinoma (PTC), medullary thyroid carcinoma (MTC), and non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Therefore, it is estimated that FNA only reaches the right diagnosis in 8% of the cases. This 92% false positive results rate can lead to an unnecessary partial or total thyroidectomy with the subsequent risks to the patients’ health and undue costs.[3-13]
The aim of this report is to review the cases of HTT diagnosed in our hospital in the past 10 years, emphasizing the cytologic features that can lead to a correct diagnosis and avoid an unnecessary total thyroidectomy.
MATERIAL AND METHODS
This is a retrospective case series from Hospital Clínico San Carlos in Madrid (Spain). Hospital Clínico is a large tertiary hospital with a population over 360,000 people and has a busy thyroid gland pathology outpatient clinic with dedicated head-and-neck radiologists and cytologists. All FNA cytologies are performed under ultrasonographic control with rapid on-site evaluation of the samples to increase diagnostic reliability.
We have performed a retrospective search of all thyroid gland resection specimens diagnosed as HTT and recorded in the electronic records (PAT-WIN) of the Pathology Department in the past 10 years.
The keywords used in the search were “hyalinizing” and “trabecular,” performing both searches separately. All cases found (n = 6) had a preoperative FNA, so we could include all the cases in the study.
The adequacy criteria for cytology samples were based on The Bethesda System for Reporting Thyroid Cytology as were the diagnosis categories employed for diagnostic classification of the cytology specimens.
In all the cases we had air-dried and alcohol fixed cytological specimens. A Papanicolaou stain had been performed at the time of diagnosis in the alcohol fixed specimens and a Diff-Quick stain in the air-dried ones. All patients had consented to their procedure following the institutional guidelines.
For the aim of this study, we only reviewed the original slides and did not perform either immunocytochemistry or molecular techniques in any of the cytologic samples.
The study has been reviewed and approved by the hospital institutional review board.
Our results are summarized in [Table 1]. In a 10-year period, we have diagnosed six cases of histology-proven HTT in our Hospital. We have a predominance of female gender with five females and one male. All patients were over 50 years of age, with a mean age of 61.3 years (range 52–68 years). Half of our lesions involved the isthmus of the thyroid. Two cases (33.3%) involved the left lobe and only one case the right lobe. The tumor size ranged from 0.7 cm to 4 cm. Most of the lesions were not larger than 2 cm (66.6%). Analyzing the ultrasonographic features, all the lesions were solid and hypoechogenic. Two of them showed microcalcifications. Only one case had a heterogeneous ultrasonographic pattern. In one case, the radiologists described a high intratumoral vascularity. Five of the six cases were diagnosed as suspicious of Follicular/Hürthle Cell Neoplasm (category IV), suspicious of PTC (category V), or positive for malignancy consistent with PTC (category VI). Only one of the cases was diagnosed as benign. In this case, the cytopathologist added a comment indicating that the cytological specimen was rich in Hürthle cells. None of them fell into the category of atypia of undetermined significance (Bethesda III). All of our patients underwent thyroidectomy and only one of them was partial. Two of these patients developed a postoperative hypothyroidism refractory to treatment with thyroid hormones. All the patients have other histologically-proven thyroid pathologies associated with the HTT. Three of them have multinodular goiter; two patients had lymphocytic thyroiditis (LT), and one patient has both pathologies. Before the diagnosis of HTT, three patients had undergone previous FNA and all of these cases had been diagnosed as category III of atypia of undetermined significance.
|Mean age||61.3 (range: 52–68)|
|Laterality of lesions|
|Hypoechogenic solid nodule||6|
|Bethesda cytological diagnostic categories|
|Associated thyroid pathologies|
[Table 2] summarizes the cytological features of our cases. All the samples showed a bloody background with little or no colloid and the smears were hyper to moderately cellular. Only one case shows little dense colloid, resembling the chewing-gum aspect of PTC associated colloid. A thorough retrospective review of the slides revealed the presence of an extracellular hyaline material in all the cases [Figure 1]. In two of them, it was abundant and in the other four cases, it was more subtle. This material is diffusely distributed through the slides and it is frequently seen around the cell groups in a small quantity. This material was overlooked at the time of diagnosis, probably misinterpreted as dense colloid [Figures 1 and 2]. Two of the cases show psammomatous calcifications [Figure 2]. None of the cases have a papillary architecture, fibrovascular cores, or abundant discohesive cells. The cells are mainly arranged in large monolayered sheets or large to small cohesive groups. The cells present an ample polygonal/fusiform cytoplasm with no clear-cut cell borders. The nucleus is central or eccentrically placed with a low nucleus to cytoplasmic ratio. None of the cases present a nuclear clearing. Three of the cases present pseudoinclusions and nuclear grooves [Figures 3 and 4]. We identified nucleoli in all cases. In two of the cases, this finding was prominent.
| Other (large sheets, macro,
and microfollicles, trabecular sheets)
|Nuclear to cytoplasmic ratio|
HTT is a rare benign lesion that occurs between the four and seventh decade of life with a marked female predilection.
The elongated or polygonal morphology of the cells together with the nuclear grooves and pseudoinclusions may lead to a misdiagnosis of PTC or FNNFPTC. The background hyaline material can be confused with MTC.[2,14-18]
HTT shows a distinctive cell membrane and cytoplasmic positivity for Ki-67, but only when clone MIB-1 is used and the reaction is performed at room temperature. It has been described both in cytological and histology specimens. If these peculiarities are not taken into account, it could result in a low-grade nuclear positivity and will lead to a misdiagnosis. HTTs are also positive for thyroglobulin and thyroid transcription factor 1, although their staining are focal and weak with hector battifora mesothelial-1 and galectin. They are usually negative for cytokeratins, chromogranin, and calcitonin.
Recently, a rearrangement of PAX8-GLIS3, and less frequently PAX8-GLS1, has been discovered. This is a particular molecular alteration seen only in HTT and not in PTC. It could be a useful tool to distinguish between both entities. All HTT demonstrated a BRAF wild-type phenotype. A BRAF mutation would exclude this entity favoring a PTC.[21-24] The immunohistochemical characteristics and molecular alterations of HTT and PTC are summarized in [Table 3].
|HBME1||Positive (focal and weak)||Positive (diffuse)|
|Galectin-3||Positive (focal and weak)||Positive (diffuse)|
|Ki67 (MIB-1 clone)||Positive (membranous)||Positive (nuclear)|
|BRAF V600E mutation||-||Present|
|PAX8-GLIS3 rearrangement||Present (most frequent)||-|
|PAX8-GLS1 rearrangement||Present (less frequent)||-|
In our series of cases, imaging studies (ultrasonography, US) are not always a helpful tool in distinguishing a HTT from a PTC, due to the overlapping radiological features, such as microcalcifications.
However, in a recent review published by Scaglietti et al., they suggest that we have to keep in mind the diagnosis of HTT when the US suggest benignancy but the cytology specimen is suggestive for PTC.
A hypercellular or moderate cytology sample with scant or no colloid, the absence of papillary or fibrovascular structures with or without nuclear pseudoinclusions that does not fit in an exact Bethesda Category requires a careful search for the presence of hyaline material.
This hyaline material may be arranged in central cores surrounded by neoplastic cells or in the background of the sheets, like Scaglietti et al. reported.
We have to be careful not to misinterpret the hyaline material as colloid or amyloid. The latter is an acellular amorphous irregular fragment with scalloped or pointed edges, that stains eosinophilic with Papanicolaou stain and deep blue with Diff-Quick stain. To identify it on cytological specimens, we suggest the possibility to perform Congo Red Staining. Distinction between hyaline material and colloid is exclusively morphological. The main problem is to distinguish dense colloid from the hyaline material. Colloid has net blunt edges as droplets and often shows glass-cracking appearance without fibrillary borders in contrast with the hyaline material of HTT. Colloid stains dark-blue with Diff-Quick Stain and orange-pink with Papanicolaou stain.
It could be helpful to perform immunochemistry with Ki-67 and molecular testing of mutations in BRAF. Even if we do not perform immunochemistry and molecular testing and we find some structures that suggest hyaline material, we could leave a note reporting that the cytology specimen has features of categories IV, V, or VI of Bethesda System, but we cannot exclude with certainty that the lesion is not a HTT. This leaves the surgeon a chance to evaluate the possibility of performing a partial thyroidectomy instead of a total thyroidectomy.
The presence of other concomitant thyroid pathologies may contribute to make the correct diagnosis more difficult and the coexistence with LT may push the cytopathologist to give a diagnosis of suspicious of PTC. It is recommended to keep in mind the high frequency of concomitant pathology in HTT.
This article has some limitations. First its retrospective nature and being based on histopathological diagnosis of this entity. We cannot be sure that some cases of this entity received a different diagnosis. In our hospital, the cytology reports did not use the Bethesda System until 2013. We have reclassified the prior cases based on the description made in the report. On the other hand, we have not full access to the radiological images, have not reviewed the cases and have only relied on the radiological report, so it is possible that we have missed some important radiological information.
HTT is a rare entity, frequently misdiagnosed in cytological samples. After reviewing our cases, we feel that the cytopathologists must be aware of the distinguishing features of this lesion, mainly the typical hyaline material and learn to differentiate it from other kinds of background material. We feel if we know this entity and its typical features proper diagnosis is possible with cytology and can reduce unnecessary aggressive management of these patients.
COMPETING INTEREST STATEMENT BY ALL AUTHORS
The authors declare no conflicts of interest regarding the publication of this paper.
AUTHORSHIP STATEMENT BY ALL AUTHORS
All authors declare that they are part of the current work through its ideation, development and revision.
ETHICS STATEMENT BY ALL AUTHORS
Study approval statement
This study protocol was reviewed and approved by Comité de Ética para la Asistencia Sanitaria (CEAS) of Hospital Clínico San Carlos, approval number [22-001].
Consent to publish statement
This study has informed consent for the use of data and images, which likewise are not linked to the patients in any way.
Data availability statement
The data used in this work are not available as they are in the private file of the Hospital Clínico San Carlos.
LIST OF ABBREVIATIONS (In alphabetic order)
FNA - Fine needle aspiration
FNNFPTC - Follicular neoplasm with nuclear features of papillary thyroid carcinoma
HBME1 - Hector battifora mesothelial-1
HTT - Hyalinizing trabecular tumor
LT - Lymphocytic thyroiditis
MNG - Multinodular goiter
MTC - Medyllary thyroid carcinoma
PTC - Papillary thyroid carcinoma
TTF1 - Thyroid transcription factor 1.
To ensure the integrity and highest quality of CytoJournal publications, the review process of this manuscript was conducted under a double-blind model (the authors are blinded for reviewers and vice versa) through automatic online system.
No specific funding was disclosed.